logo-loader
viewLithium Australia NL

Lithium Australia taking its spodumene processing technology to the next stage of commercialisation

 

Lithium Australia NL's (ASX:LIT)Adrian Griffin caught up with Proactive's Andrew Scott to discuss its quarterly update to June. He says despite the COVID-19 outbreak June was a bumper quarter for the company. Among the highlights they've been awarded a grant to build a pilot plant for their spodumene processing technology. They've also received two other grants to advance its cathode manufacturing business.

Quick facts: Lithium Australia NL

Price: 0.059 AUD

ASX:LIT
Market: ASX
Market Cap: $36.13 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lithium Australia NL named herein, including the promotion by the Company of Lithium Australia NL in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Lithium Australia's Adrian Griffin details government research grants and...

Lithium Australia's (ASX:LIT) Adrian Griffin tells Proactive London's Andrew Scott the outbreak of coronavirus so far has had very little impact on the business and its operations in China. Griffin also updates on recent developments including a grant they've been awarded by the Australian...

on 19/3/20

2 min read